"pharmaceutical composition for use in treating neoplasms and use of a compound providing dihydroartemesinin via sublingual, transmucosal, buccal or nasal dosage"
The invention provides pharmaceutical compositions for the treatment of neoplastic diseases, fluke infestations and Lyme disease, comprising compounds capable of providing dihydroartemesinin and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.